Evidence map›Paper›PMID 9312166›Full record

ArticleThe Journal of clinical investigation1997

Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.

J V Busik, S R Hootman, C A Greenidge, D N Henry

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Obesity, Diabetes and Cancer: A Mechanistic Perspective.International journal of diabetology & vascular disease research · 2015
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. High glucose inhibits HCO3(-) and fluid secretion in rat pancreatic ducts.Pflugers Archiv : European journal of physiology · 2009
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J V BusikDepartment of Physiology, Michigan State University, East Lansing, Michigan 48824, USA.
S R Hootman
C A Greenidge
D N Henry
Michigan State University · US

Funding

ALDOSE REDUCTASE EXPRESSION IN DIABETESK11DK002193 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HENRY, DOUGLAS N · 1993 to 1997
–
SIGNAL TRANSDUCTION IN THE PANCREATIC DUCT SYSTEMR01DK046607 · NIDDK · MICHIGAN STATE UNIVERSITY · PI HOOTMAN, SETH R · 1993 to 1995
–
NIDDK NIH HHS K11 DK02193NIDDK NIH HHS R01 DK46607
6 · The paper itself

Abstract

Impaired pancreatic duct secretion is frequently observed in insulin-dependent diabetes mellitus (IDDM), although the cellular mechanism(s) of dysfunction remains unknown. Studies in other tissues have suggested that a hyperglycemia-induced decrease in Na, K-ATPase activity could contribute to the metabolic complications of IDDM and that increased polyol metabolism is involved in this response. The present studies examined the effects of glucose on Na, K-ATPase activity and on expression and activity of aldose reductase (AR), a primary enzyme of polyol metabolism, in Capan-1 human pancreatic duct cells. Increasing medium glucose from 5.5 to 22 mM caused a 29% decrease in Na,K-ATPase activity. The decrease was corrected by 100 microM sorbinil, a specific AR inhibitor. Increasing glucose from 5.5 to 110 mM also resulted in concentration-dependent increases in AR mRNA and enzyme activity that could be resolved into two components, one that was glucose specific and observed at pathophysiological concentrations (< 55 mM) and a second that was osmotically induced at high concentrations (> 55 mM) and which was not glucose specific. The present study demonstrates that pathophysiological levels of glucose specifically activate polyol metabolism with a consequent decrease in Na,K-ATPase activity in pancreatic duct epithelial cells, and that this response to hyperglycemia could contribute to decreased pancreatic secretion observed in IDDM. This is the first report of AR regulation in the pancreatic duct epithelium.

Indexed as

Gene Expression Regulation, EnzymologicAldehyde ReductaseDose-Response Relationship, DrugEnzyme InductionGlucoseHumansPancreatic DuctsRNA, MessengerSodium-Potassium-Exchanging ATPaseTime FactorsTumor Cells, CulturedAldehyde ReductaseGlucoseRNA, MessengerSodium-Potassium-Exchanging ATPase

Identifiers

PMID9312166
PMCPMC508351
OpenAlexW1966399348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.